
Does Ozempic give you insomnia? Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus. Insomnia is not listed as an adverse reaction in the MHRA Summary of Product Characteristics, though some patients report sleep disturbances. Evidence for a direct causal link remains limited in clinical trial data. Sleep problems may arise indirectly through gastrointestinal discomfort, blood glucose fluctuations, or metabolic changes. If you experience sleep difficulties whilst taking Ozempic, discuss these symptoms with your GP or diabetes specialist nurse to determine the underlying cause and appropriate management strategies.
Quick Answer: Insomnia is not listed as an adverse reaction in the MHRA Summary of Product Characteristics for Ozempic, though some patients report sleep disturbances that may arise indirectly through gastrointestinal symptoms or blood glucose changes.
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. Insomnia is not listed as an adverse reaction in the Medicines and Healthcare products Regulatory Agency (MHRA) or Electronic Medicines Compendium (EMC) Summary of Product Characteristics (SmPC) for Ozempic. However, some patients report experiencing sleep disturbances whilst taking this medication.
Evidence for a causal link between Ozempic and insomnia is limited in clinical trial data and regulatory documentation. The most frequently reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and abdominal discomfort. However, sleep problems may arise indirectly through several mechanisms related to the medication's effects on the body.
It is important to recognise that sleep disturbances can result from multiple factors, including:
Changes in blood glucose levels
Gastrointestinal discomfort disrupting rest
Weight loss and metabolic changes
Anxiety or concerns about new medication
Underlying sleep disorders unrelated to Ozempic, including obstructive sleep apnoea (OSA), which is common in people with type 2 diabetes
If you are experiencing sleep difficulties after starting Ozempic, it is essential to discuss these symptoms with your GP or diabetes specialist nurse. They can help determine whether the sleep problems are related to the medication, your diabetes management, or other factors. Keeping a sleep diary noting the timing of your Ozempic injection, meals, and sleep patterns may provide valuable information for your healthcare team to assess any potential connection.

Whilst insomnia itself is not listed in the Ozempic SmPC, several common adverse reactions associated with this medication may indirectly interfere with sleep quality and duration.
Gastrointestinal symptoms are the most frequently reported side effects of Ozempic, particularly during the initial weeks of treatment or following dose escalation. According to the MHRA/EMC SmPC, these include:
Nausea – occurring in approximately 20% of patients
Vomiting – reported in approximately 8% of patients
Diarrhoea – affecting approximately 13% of patients
Abdominal pain and discomfort – cramping or bloating may make it difficult to find a comfortable sleeping position
Acid reflux or heartburn – which can worsen when lying down
Hypoglycaemia (low blood glucose) may occur, particularly when Ozempic is used in combination with sulphonylureas or insulin. The SmPC advises that dose reductions of these medications may be required when starting Ozempic. Nocturnal hypoglycaemia can cause:
Night sweats and palpitations
Vivid dreams or nightmares
Restlessness and frequent awakening
Morning headaches due to disrupted sleep architecture
Some patients report fatigue while taking Ozempic, though this is not prominently listed in the SmPC. Changes in energy levels as the body adjusts to treatment and weight loss may temporarily affect sleep patterns for some individuals.
Additionally, people with type 2 diabetes have a higher prevalence of obstructive sleep apnoea (OSA), which can cause fragmented sleep, snoring, and daytime sleepiness. Weight loss from Ozempic may eventually improve OSA symptoms, but any sleep disturbances should be evaluated by a healthcare professional.
Mounjaro® is the most innovative GLP-1 medication proven to dramatically curb appetite, hunger, and cravings to help professional men achieve substantial weight loss.
Start Here
Wegovy® is a weekly injectable GLP-1 medication with proven effectiveness in reducing appetite, hunger, and cravings to help busy professionals lose significant weight.
Start HereIf you are experiencing sleep disturbances whilst taking Ozempic, several practical strategies may help improve your sleep quality without discontinuing this important diabetes medication.
Optimising injection timing may help manage side effects. Ozempic is administered once weekly and can be given at any time of day. Due to semaglutide's long half-life, changing the time of day may have limited impact on adverse effects. If considering changing your weekly injection day, the SmPC specifies that at least 3 days must elapse between doses. Consider:
Maintaining a consistent injection day and time each week
Discussing with your GP whether adjusting injection timing might help
Dietary modifications can significantly reduce gastrointestinal side effects that interfere with sleep:
Eat smaller, more frequent meals throughout the day
Avoid large meals within 3–4 hours of bedtime
Limit fatty, spicy, or rich foods, particularly in the evening
Stay well hydrated during the day but reduce fluid intake before bed
Avoid caffeine and alcohol, which can exacerbate both gastrointestinal symptoms and sleep problems
Blood glucose monitoring is essential, particularly if you experience symptoms suggestive of nocturnal hypoglycaemia. Your diabetes team may recommend:
Checking blood glucose before bed and upon waking
Adjusting doses of other diabetes medications if hypoglycaemia occurs – do not adjust insulin or sulphonylurea doses without personalised guidance from your healthcare team
Having a small, appropriate bedtime snack if advised by your healthcare team
Sleep hygiene practices remain important, as recommended by the NHS and NICE Clinical Knowledge Summaries:
Maintain a regular sleep schedule, even at weekends
Create a cool, dark, quiet sleeping environment
Establish a relaxing bedtime routine
Limit screen time for at least one hour before bed
Consider relaxation techniques such as deep breathing or progressive muscle relaxation
If you have symptoms of obstructive sleep apnoea (snoring, witnessed breathing pauses, excessive daytime sleepiness), discuss this with your GP as you may need referral for assessment.
If sleep problems persist despite these measures, your GP may refer you for further assessment or consider whether Ozempic remains the most appropriate treatment option for your individual circumstances.
Whilst mild, temporary sleep disturbances may occur as your body adjusts to Ozempic, certain situations warrant prompt medical review to ensure your safety and optimise your diabetes management.
Contact your GP or diabetes specialist nurse if you experience:
Persistent insomnia lasting more than 2–3 weeks despite implementing sleep hygiene measures
Severe gastrointestinal symptoms that significantly disrupt sleep and daily functioning
Symptoms of hypoglycaemia, particularly nocturnal episodes, including night sweats, palpitations, confusion upon waking, or morning headaches
Excessive daytime fatigue that interferes with work, driving, or daily activities
Mood changes including low mood, anxiety, or irritability that may be related to poor sleep quality
Unexplained weight loss exceeding expected therapeutic targets
New or worsening visual symptoms, especially if you have existing diabetic retinopathy, as rapid improvement in blood glucose can temporarily worsen retinopathy
Seek urgent medical attention if you develop:
Signs of severe dehydration from vomiting or diarrhoea (reduced urination, dizziness, confusion), which can lead to acute kidney injury
Severe, persistent abdominal pain, particularly if accompanied by vomiting
Symptoms of pancreatitis (severe upper abdominal pain radiating to the back)
Call 999 for severe hypoglycaemia with confusion, loss of consciousness, or seizures
Contact NHS 111 for urgent but non-life-threatening concerns
Your healthcare team can assess whether your sleep problems are related to Ozempic or other factors. They may consider:
Dose adjustment – temporarily reducing the dose or slowing the titration schedule
Medication review – assessing other medications that might contribute to sleep problems
Alternative treatments – discussing other GLP-1 receptor agonists or diabetes medications if Ozempic is not well tolerated
Specialist referral – to a sleep clinic if an underlying sleep disorder is suspected
Never stop taking Ozempic without consulting your healthcare team, as abrupt discontinuation may affect your diabetes control. Open communication with your GP ensures that any side effects are appropriately managed whilst maintaining effective treatment of your type 2 diabetes.
If you suspect Ozempic is causing side effects, you can report these through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk), which helps monitor medication safety.
No, insomnia is not listed as an adverse reaction in the MHRA Summary of Product Characteristics for Ozempic. However, some patients report sleep disturbances that may occur indirectly through gastrointestinal symptoms, blood glucose changes, or metabolic adjustments.
Nocturnal hypoglycaemia may occur when Ozempic is used in combination with sulphonylureas or insulin. This can cause night sweats, palpitations, vivid dreams, and disrupted sleep, requiring dose adjustments of these medications under GP supervision.
Contact your GP if you experience persistent insomnia lasting more than 2–3 weeks, symptoms of nocturnal hypoglycaemia, severe gastrointestinal symptoms disrupting sleep, or excessive daytime fatigue interfering with daily activities.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.